Fosaprepitant for the prevention of nausea and emesis during five weeks of chemo-radiotherapy: a multinational randomised, placebo-controlled, double-blind trial - the GAND-emesis study

Christina H. B. Ruhlmann, T B Christensen, L H Dohn, M Paludan, E Rønnengart, F Hilbert, P Feyer, G Kristensen, D Keefe, Olfred Hansen, Jørn Herrstedt

Publikation: Konferencebidrag uden forlag/tidsskriftKonferenceabstrakt til konferenceForskningpeer review

OriginalsprogEngelsk
Publikationsdato2015
StatusUdgivet - 2015
BegivenhedEuropean Cancer Congress (ECC) 2015 - Wien, Østrig
Varighed: 25. sep. 201529. sep. 2015

Konference

KonferenceEuropean Cancer Congress (ECC) 2015
Land/OmrådeØstrig
ByWien
Periode25/09/201529/09/2015

Citationsformater